Dr. Batlevi on Emerging Therapies in Follicular Lymphoma

September 25, 2020

Connie L. Batlevi, MD, PhD, discusses emerging therapies in follicular lymphoma.

Connie L. Batlevi, MD, PhD, a medical oncologist specializing in lymphoma at Memorial Sloan Kettering Cancer Center, discusses emerging therapies in follicular lymphoma.

​Several emerging therapies ​in the follicular lymphoma pipeline ​have shown encouraging data, says Batlevi.

Strategies based on modulating immune response have comprised a significant area of research, ​Batlevi explains. Additionally, the utility of CAR T-cell therapy, antibody​-drug conjugates, and bispecific antibodies ​is also being evaluated.

​Future research efforts should focus on identifying an optimal sequencing method ​for patients with follicular lymphoma, especially as more options are introduced to the armamentarium, Batlevi concludes. 


x